Rigel Pharmaceuticals (RIGL)

P/S ratio as of November 2024 (TTM): 3.68

According to Rigel Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -16.0. At the end of 2024 the company had a P/S ratio of 1.11.

P/S ratio history for Rigel Pharmaceuticals from 2001 to 2024

PS ratio at the end of each year

Year	P/S ratio	Change
2024	1.11	-48.79%
2023	2.16	0.33%
2022	2.16	-29%
2021	3.04	-44.23%
2020	5.44	-10.2%
2019	6.06	-29.81%
2018	8.64	-93.19%
2017	127	997.26%
2016	11.6	21.66%
2015	9.50	-60.8%
2014	24.2	-30.56%
2013	34.9	-86.14%
2012	252	112.73%
2011	118	3658.21%
2010	3.15	-99.52%
2009	659
2007	50.7	467.34%
2006	8.93	-28.87%
2005	12.6	-87.63%
2004	101	293.89%
2003	25.8	708.06%
2002	3.19	-72.2%
2001	11.5

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
ChemoCentryx CCXI	101	2,631.51%	🇺🇸 USA
Sangamo Therapeutics SGMO	46.0	1,149.05%	🇺🇸 USA
AstraZeneca AZN	4.11	11.80%	🇬🇧 UK
Amgen AMGN	4.94	34.18%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Rigel Pharmaceuticals (RIGL)

P/S ratio as of November 2024 (TTM): 3.68